Stocks and Investing Stocks and Investing
Fri, March 11, 2022
Thu, March 10, 2022
Wed, March 9, 2022
Tue, March 8, 2022

Asthika Goonewardene Initiated (ACET) at Strong Buy and Held Target at $30 on, Mar 8th, 2022


Published on 2024-10-27 20:00:28 - WOPRAI, Asthika Goonewardene
  Print publication without navigation


Asthika Goonewardene of Truist Securities, Initiated "Adicet Bio, Inc." (ACET) at Strong Buy and Held Target at $30 on, Mar 8th, 2022.

Asthika has made no other calls on ACET in the last 4 months.



There are 2 other peers that have a rating on ACET. Out of the 2 peers that are also analyzing ACET, 0 agree with Asthika's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Asthika


  • Kelly Shi of "Jefferies" Initiated at Strong Buy and Held Target at $27 on, Friday, March 4th, 2022
  • Michael Schmidt of "Guggenheim" Maintained at Strong Buy with Increased Target to $32 on, Monday, December 6th, 2021